BIO-key International Inc. (NASDAQ:BKYI – Get Free Report) was the recipient of a large decline in short interest in the month of July. As of July 15th, there was short interest totaling 1,399 shares, a decline of 68.4% from the June 30th total of 4,425 shares. Approximately 0.1% of the shares of the company are short sold. Based on an average daily trading volume, of 34,947 shares, the days-to-cover ratio is currently 0.0 days.
Analysts Set New Price Targets
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of BIO-key International in a report on Friday, July 17th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has an average rating of “Sell”.
Check Out Our Latest Stock Analysis on BKYI
BIO-key International Price Performance
Institutional Inflows and Outflows
A hedge fund recently raised its stake in BIO-key International stock. Geode Capital Management LLC raised its stake in shares of BIO-key International Inc. (NASDAQ:BKYI – Free Report) by 49.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 48,892 shares of the technology company’s stock after acquiring an additional 16,271 shares during the quarter. Geode Capital Management LLC owned approximately 0.45% of BIO-key International worth $26,000 as of its most recent filing with the SEC. Institutional investors own 26.51% of the company’s stock.
About BIO-key International
BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.
In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.
See Also
- Five stocks we like better than BIO-key International
- AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next
- Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now
- Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There?
- Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.
